Abstract:Background Fetal echocardiography has been the mainstay of fetal arrhythmia diagnosis; however, fetal magnetocardiography (fMCG) has recently become clinically available. We sought to determine to what extent fMCG contributed to the precision and accuracy of fetal arrhythmia diagnosis and risk assessment, and in turn, how this altered pregnancy management. Methods and Results We reviewed fMCG tracings and medical records of 215 pregnancies referred to the Biomagnetism Laboratory, UW‐Madison, over the last 10 years, because of fetal arrhythmia or risk of arrhythmia. We compared referral diagnosis and treatment with fMCG diagnosis using a rating scale and restricted our review to the 144 subjects from the tachycardia, bradycardia/AV block, and familial long QT syndrome categories. Additional fMCG findings beyond those of the referring echocardiogram, or an alternative diagnosis were seen in 117/144 (81%), and 81 (56%) were critical changes. Eight (5.5%) had resolution of arrhythmia before fMCG. At least moderate changes in management were seen in 109/144 (76%) fetuses, of which 35/144 (24%) were major. The most diverse fMCG presentation was long QT syndrome, present in all 3 referral categories. Four of 5 stillbirths were seen with long QT syndrome. Nine fetuses showed torsades de pointes ventricular tachycardia, of which only 2 were recognized before fMCG. Conclusions FMCG has a significant impact on prenatal diagnosis and management of arrhythmias or familial arrhythmia risk, which cannot be fully met by existing technology. The combination of fMCG and fetal echocardiography in fetal care centers will be needed in the future to optimize care. Nonstandard Abbreviations and Acronyms AVB atrioventricular block BAB blocked atrial bigeminy fMCG fetal magnetocardiography LQTS long QT syndrome PVCs premature ventricular contractions SSA/Ro Sjogren's antibody A SVT supraventricular tachycardia TdP torsades de pointes ventricular tachycardia TWA T wave alternans Clinical Perspective What Is New? Fetal magnetocardiography (fMCG) is an advanced technology similar to postnatal electrocardiography or Holter monitoring. In 144 high‐risk pregnant subjects with or at risk for fetal arrhythmias related to tachycardia, atrioventricular block, and long QT syndrome, fMCG supplemented and/or changed the clinical diagnosis in over half of fetuses studied by (1) dispelling ambiguity of echocardiographic rhythm diagnosis, and/or (2) uncovering new unsuspected rhythm or conduction abnormalities. What Are the Clinical Implications? fMCG findings led to major clinical fetal–maternal management changes in one quarter of patients, often resulting in a safer maternal care plan. Seven of 9 cases of torsades de pointes were not detected by echocardiography before fMCG. Correct fetal rhythm diagnosis provided by a combination of fMCG and fetal echocardiography, in the future, may improve maternal–fetal outcomes. Fetal magnetocardiography (fMCG) is a promising technology that safely and noninvasively records the natural electromagnetic signal of the fetal heart. 1 , 2 , 3 New optically pumped magnetometer sensors, and person‐sized magnetic shields have lowered technology cost and will likely soon facilitate broader adoption. 4 , 5 Like postnatal ECG, fMCG allows precise assessment of cardiac time intervals (RR, P, PR, QRS, QT, U, and QTc), signal characteristics, and diverse rhythm patterns. The Scientific Statement of the American Heart Association supports the use of fMCG to assess cardiac conduction and rhythm in fetuses with known or suspected conduction system abnormalities, a Category 2a recommendation (ie, benefits>>risks) and stated that no other techni -Abstract Truncated-

Fetal cardiac arrhythmia detection and in utero therapy

Application of Fetal Echocardiography in Detection of Fetal Arrhythmia and Its Clinical Significance

Clinical Application of Echocardiography in Detection of Foetal Arrhythmia:A Retrospective Study of 451 Foetuses

Fetal Arrhythmia Diagnosis and Pharmacologic Management

Quantitative study of fetal heart conduction time intervals by tissue Doppler imaging and pulse Doppler echocardiography

Evaluation of Fetal Cardiac Conduction Time by Simultaneous Recording of Doppler Blood Flow Spectrum of Fetal Pulmonary Artery and Vein

Fetal arrhythmias: diagnosis and treatment

Application of Doppler Tissue Imaging in Diagnosis of Fetal Arrhythmias

Treatment of Fetal Arrhythmias

Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association

Contribution of Fetal Magnetocardiography to Diagnosis, Risk Assessment, and Treatment of Fetal Arrhythmia.

Expert guidance on prenatal treatment and management for fetal arrhythmia

Intrauterine management of fetal arrhythmia

Preventing and Treating Torsades de Pointes in the Mother, Fetus and Newborn in the Highest Risk Pregnancies with Inherited Arrhythmia Syndromes

Diagnosis and the clinical significance of fetal arrhythmias

Tachyarrhythmias in congenital heart disease

[Cardiac arrhythmias in adults with congenital heart disease]

Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association

Diagnosis and treatment of neonatal arrhythmia

Cardiac Arrhythmias and Their Management: An In-Depth Review of Current Practices and Emerging Therapies

Peripartum management of cardiac arrhythmias: a narrative review